ReviewWorld journal of transplantation2014
ABO incompatible renal transplants: Good or bad?
Review in World journal of transplantation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 57 citations in OpenAlex.
- A Biomimetic Nanoparticle System Intercepts and Degrades Thrombospondin-1 to Restore Vascular Homeostasis After Ischemic Injury.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- A comparative study on outcomes of ABO-incompatible kidney transplants between robot-assisted vs. open surgery-propensity score-matched analysis: a retrospective cohort study.BMC nephrology · 2024Article
- Therapeutic apheresis in kidney diseases: an updated review.Renal failure · 2022Review
- Patient and Graft Survival After A1/A2-incompatible Living Donor Kidney Transplantation.Transplantation direct · 2022Article
- Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective.Journal of cancer research and clinical oncology · 2022Review
- Identification of an activation-related protein in B cells in the ABO incompatible condition.Experimental and therapeutic medicine · 2020Article
- Polyoma virus nephropathy in kidney transplantation.World journal of transplantation · 2017Review
- Fifteen-Year Analysis of Deceased Kidney Donation: A Single Transplant Center Experience in a Region of Northern Italy.Medical science monitor : international medical journal of experimental and clinical research · 2017Article
- Production of human blood group B antigen epitope conjugated protein in Escherichia coli and utilization of the adsorption blood group B antibody.Microbial cell factories · 2016Article
- Ongoing higher infection rate in ABO-incompatible kidney transplant recipient: is it a serious problem? A single-center experience.Annals of surgical treatment and research · 2016Article
- Treatment of large plasma volumes using specific immunoadsorption to desensitize ABO-incompatible kidney-transplant candidates.Journal of nephropathology · 2016Article
- Potential Roles for C1 Inhibitor in Transplantation.Transplantation · 2016Review
- Renal transplantation in infants.Pediatric nephrology (Berlin, Germany) · 2016Review
- Comparison of clinical outcomes between ABO-compatible and ABO-incompatible spousal donor kidney transplantation.Kidney research and clinical practice · 2016Article
- Excellent long term patient and renal allograft survival after ABO-incompatible kidney transplantation: Experience of one center.World journal of transplantation · 2015Article
- One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts.Clinical transplantation · 2015Article
- Immunoadsorption Column Reuse.Indian journal of nephrologyArticle
- Immunoadsorption in ABO-incompatible kidney transplantation in adult and pediatric patients with follow-up on graft and patient survival: First series from India.Asian journal of transfusion scienceArticle
- Successful Renal Transplantation Across HLA Barrier: Report from India.Indian journal of nephrologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ABO incompatible kidney transplantation (ABOi-KT) was previously considered to be an absolute contraindication for patients with end-stage kidney disease (ESKD) due to hyperacute rejection related to blood type barrier. Since the first successful series of ABOi-KT was reported, ABOi-KT is performed increasingly all over the world. ABOi-KT has led to an expanded donor pool and reduced the number of patients with ESKD awaiting deceased kidney transplantation (KT). Intensified immunosuppression and immunological understanding has helped to shape current desensitization protocols. Consequently, in recent years, ABOi-KT outcome is comparable to ABO compatible KT (ABOc-KT). However, many questions still remain unanswered. In ABOi-KT, there is an additional residual immunological risk that may lead to allograft damage, despite using current diverse but usually intensified immunosuppressive protocols at the expense of increasing risk of infection and possibly malignancy. Notably, in ABOi-KT, desensitization and antibody reduction therapies have increased the cost of KT. Reassuringly, there has been an evolution in ABOi-KT leading to a simplification of protocols over the last decade. This review provides an overview of the history, outcome, protocol, advantages and disadvantages in ABOi-KT, and focuses on whether ABOi-KT should be recommended as a therapeutic option of KT in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.